Drugs / Azilsartan medoximil
Azilsartan medoximil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01774591 Comparator | Jan 2013 → Nov 2015 | hypertensive disorder | University of Chicago | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Azilsartan medoximil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01774591 ↗ |
| Known as | azilsartan | “All subjects were randomized to 80mg azilsartan medoxomil (azilsartan) daily or placebo and followed for six months.” NCT01774591 ↗ |
| Known as | azilsartan medoxomil | “All subjects were randomized to 80mg azilsartan medoxomil (azilsartan) daily or placebo and followed for six months.” NCT01774591 ↗ |
| Route | Oral | “80 mg of azilsartan medoximil tablets by mouth each day.” NCT01774591 ↗ |